Who owns Structure Therapeutics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of GPCR from SEC Form 13F filings across 170 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 170 institutions disclosed 67.9M shares of Structure Therapeutics Inc. worth $2.12B — about 93.2% of shares outstanding; the largest disclosed holder is WELLINGTON MANAGEMENT GROUP LLP. Source: SEC Form 13F filings, parsed by EvidInvest.
170
13F holders
$2.12B
value, 2026 filers
93.2%
of shares outstanding (67.9M sh)
27
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of GPCR's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | WELLINGTON MANAGEMENT GROUP LLP | 9.8M | $305.3M | 0.1% | 13.4% | +32.3% |
| 2 | FMR LLC | 9.4M | $292.5M | 0.0% | 12.8% | +19.8% |
| 3 | Avoro Capital Advisors LLC | 6.6M | $205.0M | 2.1% | 9% | 0.0% |
| 4 | Janus Henderson Group Ltd.NEW | 5.1M | $158.5M | 0.1% | 7% | new |
| 5 | Deep Track Capital, LP | 5.0M | $156.3M | 2.5% | 6.9% | +5.5% |
| 6 | MORGAN STANLEY | 2.8M | $88.1M | 0.0% | 3.9% | +0.4% |
| 7 | BVF INC/IL | 2.7M | $84.2M | 2.8% | 3.7% | -20.1% |
| 8 | RTW INVESTMENTS, LP | 2.3M | $71.4M | 0.7% | 3.1% | +42.0% |
| 9 | BAKER BROS. ADVISORS LP | 1.4M | $44.8M | 0.2% | 2% | 0.0% |
| 10 | ORBIMED ADVISORS LLC | 1.3M | $41.6M | 0.8% | 1.8% | -39.8% |
| 11 | Paradigm Biocapital Advisors LPNEW | 1.3M | $40.6M | 0.8% | 1.8% | new |
| 12 | PRINCIPAL FINANCIAL GROUP INC | 1.3M | $39.6M | 0.0% | 1.7% | -27.8% |
| 13 | DEERFIELD MANAGEMENT COMPANY, L.P. | 1.1M | $34.0M | 0.5% | 1.5% | 0.0% |
| 14 | Casdin Capital, LLC | 1.0M | $32.2M | 1.4% | 1.4% | -12.3% |
| 15 | Logos Global Management LP | 1.0M | $31.3M | 1.7% | 1.4% | +100.0% |
| 16 | Siren, L.L.C. | 872,967 | $27.3M | 0.6% | 1.2% | 0.0% |
| 17 | Aberdeen Group plc | 858,784 | $26.9M | 0.0% | 1.2% | +34.2% |
| 18 | CAPITOLIS LIQUID GLOBAL MARKETS LLC | 835,000 | $26.1M | 0.1% | 1.1% | -19.8% |
| 19 | Driehaus Capital Management LLC | 803,818 | $25.1M | 0.2% | 1.1% | -48.2% |
| 20 | Pacific Heights Asset Management LLC | 800,000 | $25.0M | 0.8% | 1.1% | 0.0% |
| 21 | BlackRock, Inc. | 705,946 | $22.1M | 0.0% | 1% | +38.1% |
| 22 | Rock Springs Capital Management LP | 640,317 | $20.0M | 1.1% | 0.9% | 0.0% |
| 23 | ALLIANCEBERNSTEIN L.P. | 581,971 | $18.2M | 0.0% | 0.8% | -4.9% |
| 24 | JPMORGAN CHASE & CO | 546,189 | $17.9M | 0.0% | 0.7% | +13609.6% |
| 25 | Blue Sparrow, LLC /DENEW | 473,200 | $14.8M | 0.2% | 0.6% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.